American Hospital Association January 10, 2025

Prices for the top 25 brand-name Medicare Part D drugs have increased by an average of 98% since entering the market, according to a report released Jan. 9 by the AARP Public Policy Institute. That price growth has often exceeded...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Insurance, Medicare, Pharma, Pharma / Biotech, Survey / Study, Trends
Value-based payment models: Doctors describe the disconnect between theory and practice
Nurse anesthetists outnumber anesthesiologists billing Medicare
OIG report finds just 40% of Medicare enrollees who started treatment for opioid use disorder continued
Fewer psychiatrists are billing Medicare: 5 things to know
Psychiatrists participating in Medicare Part B declines: Study

Share This Article